$595 Million is the total value of SECTOR GAMMA AS's 33 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 54.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $58,658,000 | +31.1% | 1,128,470 | +56.5% | 9.86% | +40.6% |
| GILD | Buy | GILEAD SCIENCES INC | $27,169,000 | +8.9% | 434,357 | +34.4% | 4.57% | +16.8% |
| NUVA | Buy | NUVASIVE INC | $23,488,000 | -16.3% | 473,923 | +19.9% | 3.95% | -10.2% |
| INCY | Buy | INCYTE CORP | $21,394,000 | +44.9% | 336,444 | +57.4% | 3.60% | +55.4% |
| A | Buy | AGILENT TECHNOLOGIES INC | $21,253,000 | +41.3% | 315,051 | +47.7% | 3.57% | +51.5% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $20,512,000 | +96.4% | 379,421 | +87.4% | 3.45% | +110.7% |
| CVS | New | CVS HEALTH CORP | $17,472,000 | – | 266,670 | +100.0% | 2.94% | – |
| CELG | New | CELGENE CORP | $16,856,000 | – | 263,000 | +100.0% | 2.83% | – |
| QGEN | New | QIAGEN NV | $14,035,000 | – | 407,406 | +100.0% | 2.36% | – |
| PDCO | Buy | PATTERSON COMPANIES INC | $9,481,000 | -18.8% | 482,263 | +1.0% | 1.59% | -12.9% |
| AGN | New | ALLERGAN PLC | $9,356,000 | – | 70,000 | +100.0% | 1.57% | – |
| CAH | Buy | CARDINAL HEALTH INC | $9,203,000 | +25.0% | 206,335 | +51.3% | 1.55% | +34.1% |
| MCK | New | MCKESSON CORP | $6,242,000 | – | 56,500 | +100.0% | 1.05% | – |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $6,027,000 | +10.6% | 335,577 | +80.8% | 1.01% | +18.6% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $5,557,000 | -22.6% | 284,701 | +5.6% | 0.93% | -17.1% |
| THC | New | TENET HEALTHCARE CORP | $4,600,000 | – | 268,388 | +100.0% | 0.77% | – |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $4,334,000 | +9.0% | 59,437 | +30.8% | 0.73% | +16.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-08 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.